Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 12 years of Shares Outstanding data on record, last reported at $29.5 million in Q1 2022.

  • For Q1 2022, Shares Outstanding rose 0.54% year-over-year to $29.5 million; the TTM value through Feb 2022 reached $29.5 million, up 0.54%, while the annual FY2021 figure was $29.3 million, 0.37% changed from the prior year.
  • Shares Outstanding reached $29.5 million in Q1 2022 per LFCR's latest filing, roughly flat from $29.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $29.5 million in Q1 2022 and bottomed at $27.6 million in Q1 2018.
  • Average Shares Outstanding over 5 years is $28.9 million, with a median of $29.2 million recorded in 2020.
  • Peak YoY movement for Shares Outstanding: grew 5.27% in 2019, then grew 0.33% in 2020.
  • A 5-year view of Shares Outstanding shows it stood at $27.8 million in 2018, then grew by 4.96% to $29.2 million in 2019, then increased by 0.55% to $29.3 million in 2020, then rose by 0.54% to $29.5 million in 2021, then rose by 0.0% to $29.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $29.5 million in Q1 2022, $29.5 million in Q4 2021, and $29.5 million in Q3 2021.